Rapport Therapeutics, Inc. Common Stock logo

RAPPRapport Therapeutics, Inc. Common Stock

RAPP Stock Price, Valuation & Chart | Rapport Therapeutics, Inc. Common Stock

Compare

RAPP Historical price chart

RAPP Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization2.33B
PE Ratio-16.02
EPS-3.04
Trading Volume294.68K
Today's High/Low50.34/47.73
Dividend Yield0.00
52 Week High/Low52.93/14.11
Shares Outstanding47.83M
RAPP Financial Statement
RAPP Analyst ratings
RAPP Analysis & performance metrics

RAPP Company profile

Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines…

RAPP Management team

Management
Troy A. IgnelziCFO
Chief Financial Officer
Swamy Yeleswaram Ph.D.
Chief Development Officer
Arnold R. Gammaitoni Pharm.D.
Senior Vice President of Medical Affairs
Kathleen A. Wilkinson
Chief People Officer
David Bredt M.D., Ph.D.
Founder & Chief Scientific Officer
Steven M. Paul M.D.
Founder & Independent Chairman
Abraham N. Ceesay M.B.A.CEO
Chief Executive Officer, President, Treasurer & Director
Cheryl GaultCOO
Chief Operating Officer
Total 8 executives

RAPP Frequently asked questions

What is Rapport Therapeutics, Inc. Common Stock (RAPP) Stock Price?

Current stock price of Rapport Therapeutics, Inc. Common Stock (RAPP) stock is $48.690. The stock price is +0.27% higher in the session. The intraday range can be seen from this page. Volume of Rapport Therapeutics, Inc. Common Stock (RAPP) stock is 294.68K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Rapport Therapeutics, Inc. Common Stock (RAPP) stock price going up or down today?

The stock price of Rapport Therapeutics, Inc. Common Stock (RAPP) can change with earnings, company news, and overall market sentiment. Rapport Therapeutics, Inc. Common Stock operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Rapport Therapeutics, Inc. Common Stock stock expensive at its current price?

Whether Rapport Therapeutics, Inc. Common Stock looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for RAPP on this page is -16.02. EPS on this page is -3.04. Compare those figures with peers and growth expectations before deciding if the current Rapport Therapeutics, Inc. Common Stock price is justified.

How has the stock price of Rapport Therapeutics, Inc. Common Stock (RAPP) performed historically?

Historical performance for Rapport Therapeutics, Inc. Common Stock (RAPP) is shown on the price chart on this page. Review multi-period moves alongside volume to see how RAPP reacted to past earnings and market events.

Should I buy Rapport Therapeutics, Inc. Common Stock (RAPP) stock, at this price?

Buying Rapport Therapeutics, Inc. Common Stock (RAPP) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.